Expressing the sense of the House of Representatives that the Food and Drug Administration has the authority to approve drugs for abortion care.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
The bill requires that it is the sense of the House of Representatives that— by enacting the Federal Food, Drug, and Cosmetic Act and subsequent amendments, Congress intended for and authorized the Food and Drug Administration. It relies on reporting requirements and product standards. The main policy areas are Healthcare Consumers and Healthcare.
Who Benefits and How
Public beneficiaries or protected communities affected by the clause could face reduced risk.
Who Bears the Burden and How
Federal, state, or local agencies responsible for implementing the clause would take on compliance duties and Patients and health care consumers affected by the bill would take on compliance duties.
Key Provisions
- Requires that it is the sense of the House of Representatives that— by enacting the Federal Food, Drug, and Cosmetic Act and subsequent amendments, Congress intended for and authorized the Food and Drug Administration...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
The bill requires that it is the sense of the House of Representatives that— by enacting the Federal Food, Drug, and Cosmetic Act and subsequent amendments, Congress intended for and authorized the Food and Drug Administration.
Key Policy Areas
Healthcare Consumers, Healthcare
Primary Purpose
The bill requires that it is the sense of the House of Representatives that— by enacting the Federal Food, Drug, and Cosmetic Act and subsequent amendments, Congress intended for and authorized the Food and Drug Administration.
Policy Domains
Whole bill
Identified Gains
- Public beneficiaries or protected communities affected by the clause
Identified Costs
- Federal, state, or local agencies responsible for implementing the clause
- Patients and health care consumers affected by the bill
Sponsors
Legislative Progress
In CommitteeMs. Manning (for herself, Ms. Caraveo, Ms. Meng, Ms. Norton, …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology